169 related articles for article (PubMed ID: 17588793)
1. Strabismus in adults with uveal melanoma following episcleral plaque brachytherapy.
Dawson E; Sagoo MS; Mehta JS; Comer R; Hungerford J; Lee J
J AAPOS; 2007 Dec; 11(6):584-8. PubMed ID: 17588793
[TBL] [Abstract][Full Text] [Related]
2. Ocular motility disturbances after episcleral plaque brachytherapy for uveal melanoma.
Sener EC; Kiratli H; Gedik S; Sanac AS
J AAPOS; 2004 Feb; 8(1):38-45. PubMed ID: 14970798
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Strabismus Post-Plaque Brachytherapy in Patients With Uveal Melanoma.
Huang JJ; Saleem A; Liao EX; Larocque M; Menon G; Murtha A; Solarte C; Weis E
Am J Ophthalmol; 2024 Jun; 262():161-169. PubMed ID: 38307213
[TBL] [Abstract][Full Text] [Related]
4. Extraocular muscle repositioning and diplopia: associated with ophthalmic plaque radiation therapy for choroidal melanoma.
Nagendran ST; Finger PT; Campolattaro BN
Ophthalmology; 2014 Nov; 121(11):2268-74. PubMed ID: 25062940
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of strabismus following choroidal melanoma plaque brachytherapy.
Alfreihi SH; Pineles SL; McCannel TA; Prada AM; Velez FG
J AAPOS; 2017 Aug; 21(4):286-290.e2. PubMed ID: 28728906
[TBL] [Abstract][Full Text] [Related]
6. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural alterations in extraocular muscles following iodine-125 brachytherapy for uveal melanoma.
Kïratlï H; Yïlmaz PT; Sargon M
Strabismus; 2007; 15(2):103-9. PubMed ID: 17564940
[TBL] [Abstract][Full Text] [Related]
8. Disease control and toxicity outcomes using ruthenium eye plaque brachytherapy in the treatment of uveal melanoma.
Takiar V; Gombos DS; Mourtada F; Rechner LA; Lawyer AA; Morrison WH; Garden AS; Beadle BM
Pract Radiat Oncol; 2014; 4(4):e189-94. PubMed ID: 25012839
[TBL] [Abstract][Full Text] [Related]
9. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
[TBL] [Abstract][Full Text] [Related]
10. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.
Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD
JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414
[TBL] [Abstract][Full Text] [Related]
11. [Motility disorders in brachytherapy of choroid melanomas with Ru106 applicators].
Langmann A; Langmann G; Unlücerci C; Haller E
Ophthalmologe; 1995 Feb; 92(1):76-8. PubMed ID: 7719082
[TBL] [Abstract][Full Text] [Related]
12. A choice of radionuclide: Comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma.
Takiar V; Voong KR; Gombos DS; Mourtada F; Rechner LA; Lawyer AA; Morrison WH; Garden AS; Beadle BM
Pract Radiat Oncol; 2015; 5(3):e169-e176. PubMed ID: 25423888
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: a mono-institutional experience.
Perri P; Fiorica F; D'Angelo S; Lamberti G; Parmeggiani F; Martini A; Carpenteri F; Colosimo C; Micucci M; Perazzini L; De Gugliemo E; Berretta M; Sebastiani A; Cartei F
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1919-24. PubMed ID: 23242717
[TBL] [Abstract][Full Text] [Related]
14. Intraocular pressure elevation during radioactive plaque brachytherapy for uveal melanoma.
Bhatia SK; Covert DJ; Wirostko WJ
Arch Ophthalmol; 2011 May; 129(5):668-9. PubMed ID: 21555626
[No Abstract] [Full Text] [Related]
15. The Impacts of Episcleral Plaque Brachytherapy on Ocular Motility.
Abri Aghdam K; Soltan Sanjari M; Naseripour M; Manafi N; Sedaghat A; Bakhti S
J Binocul Vis Ocul Motil; 2021; 71(2):55-61. PubMed ID: 33830859
[No Abstract] [Full Text] [Related]
16. Botulinum toxin injection for postoperative diplopia testing in adult strabismus.
Khan J; Kumar I; Marsh IB
J AAPOS; 2008 Feb; 12(1):46-8. PubMed ID: 17964210
[TBL] [Abstract][Full Text] [Related]
17. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
18. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
[TBL] [Abstract][Full Text] [Related]
19. Ocular complications after iodine brachytherapy for large uveal melanomas.
Puusaari I; Heikkonen J; Kivelä T
Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
[TBL] [Abstract][Full Text] [Related]
20. Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study.
Kaliki S; Shields CL; Rojanaporn D; Badal J; Devisetty L; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2013 May; 120(5):1004-11. PubMed ID: 23347983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
